New therapy helps to improve stereoscopic vision in stroke patients

Psychologists at Saarland University have developed a novel therapy to help people who are experiencing impaired spatial vision, possibly as a result of a stroke. The researchers use what are known as convergent eye movement. Patients try to fuse the two images to a single image. Credit: Oliver Dietze

Humans view the world through two eyes, but it is our brain that combines the images from each eye to form a single composite picture. If this function becomes damaged, impaired sight can be the result. Such loss of visual function can be observed in patients who have suffered a stroke or traumatic brain injury or when the oxygen supply to the brain has been reduced (cerebral hypoxia). Those affected by this condition experience blurred vision or can start to see double after only a short period of visual effort. Other symptoms can include increased fatigue or headaches. It is been suggested that these symptoms arise because the brain is unable to maintain its ability to fuse the separate images from each eye into a single composite image over a longer period. Experts refer to this phenomenon as binocular fusion dysfunction.

'As a result, these have significantly reduced visual endurance,' explains Katharina Schaadt, a graduate psychology student at Saarland University. 'This often severely limits a patient's ability to work or go about their daily life.' Working at a computer screen or reading the newspaper can be very challenging. As binocular fusion is a fundamental requirement for achieving a three-dimensional impression of depth, those affected also frequently suffer from partial or complete stereo blindness. 'Patients suffering from stereo blindness are no longer able to perceive spatial depth correctly,' says Schaadt. 'In extreme cases, the world appears as flat as a two-dimensional picture. Such patients may well have difficulties in reaching for an object, climbing stairs or walking on uneven ground.'

Although about 20% of and up to 50% of patients with trauma injuries suffer from these types of functional impairments, there is still no effective therapy. Researchers at Saarland University working with Anna Katharina Schaadt and departmental head Professor Georg Kerkhoff have now developed a novel therapeutic approach and have examined its efficacy in two studies. 'Test subjects underwent a six week training program in which both eyes were exercised equally,' explains Schaadt. The aim was to train binocular fusion and thus improve three-dimensional vision. Participants in the study were presented with two images with a slight lateral offset between them. By using what are known as convergent eye movements, patients try to fuse the two images to a single image. This involves directing the eyes inward towards the nose while always keeping the images in the field of view. With time, the two images fuse to form a single image that exhibits stereoscopic depth, i.e. the patient has re-established binocular single vision.

The team of clinical neuropsychologists at Saarland University have used this training programme on eleven stroke patients, nine patients with injury and four hypoxia patients. After completing the training programme, a significant improvement in binocular fusion and stereoscopic vision was observed in all participants. In many cases, a normal level of stereovision was attained. 'The results remained stable in the two post-study examinations that we performed after three and six months respectively,' says Schaadt. 'Visual endurance also improved significantly.' Patients who were able to work at a computer for only 15 to 20 minutes before they began treatment found that they could work at a computer screen for up to three hours after completing the therapeutic training programme.

The results are also of theoretical value to the Saarbrücken scientists, as they provide insight into brain function and indicate that certain regions of the brain that have been become damaged can be reactivated if the appropriate therapy is used.

More information: Schaadt, A.-K., Schmidt, L., Kuhn, C., Summ, M., Adams, Garbacenkaite, R., Leonhardt, E., Reinhart, S., Kerkhoff, G. (2013) "Perceptual relearning of binocular fusion after hypoxic brain damage: four controlled single-case treatment studies." Neuropsychology, in press. DOI: 10.1037/neu0000019

Schaadt, A.-K., Schmidt,L., Reinhart, S., Adams, M., Garbacenkaite, R., Leonhardt, E., Kuhn, C., Kerkhoff, G. (2013) "Perceptual relearning of binocular fusion and stereoacuity after brain injury." Neurorehabilitation & Neural Repair, in press. DOI: 1545968313516870

add to favorites email to friend print save as pdf

Related Stories

Team IDs binocular vision gene

Sep 14, 2007

In work that could lead to new treatments for sensory disorders in which people experience the strange phenomena of seeing better with one eye covered, MIT researchers report that they have identified the gene responsible ...

Paper examines the illusion of the scintillating grid

Dec 19, 2012

(Medical Xpress)—The fascinating but deeply weird illusion of the scintillating grid, where the grid appears to sparkle, has been shown to be more sparkly when you view it with both eyes rather than one ...

Recommended for you

A new cause of mental disease?

3 hours ago

Astrocytes, the cells that make the background of the brain and support neurons, might be behind mental disorders such as depression and schizophrenia, according to new research by a Portuguese team from ...

Molecular basis of age-related memory loss explained

Jul 22, 2014

From telephone numbers to foreign vocabulary, our brains hold a seemingly endless supply of information. However, as we are getting older, our ability to learn and remember new things declines. A team of ...

The neurochemistry of addiction

Jul 22, 2014

We've all heard the term "addictive personality," and many of us know individuals who are consistently more likely to take the extra drink or pill that puts them over the edge. But the specific balance of ...

Study examines blood markers, survival in patients with ALS

Jul 21, 2014

The blood biomarkers serum albumin and creatinine appear to be associated with survival in patients with amyotrophic lateral sclerosis (ALS) and may help define prognosis in patients after they are diagnosed with the fatal ...

User comments